Ashraf El-Hinnawi, MD, and Georgios Vrakas, MD, MSc, PhD, FRCS, discuss advancements in kidney transplantation at UF Health, highlighting their success in increasing transplant volume and improving outcomes. They emphasize the importance of expanding living-kidney donations, managing waitlists, and exploring future research in xenotransplantation to address the organ shortage.

Dr. Maryam Rahman shares insight on the role of laser ablation in the treatment of brain tumors.

1. Review bronchiolitis pathophysiology and epidemiology.
2. Discuss the 2014 clinical guidelines on bronchiolitis.
3. Describe de-implementation strategies and projects related to bronchiolitis management.

1. Gain updated information on the current status of hemophilia gene therapy.
2. Understand the limitations of the first generation of AAV vectors currently in use.
3. Learn about the strategies being developed to mitigate those limitations.

As a result of participation in this activity, participants should be able to:
1. Understand the current HPV-related cancer epidemic: concerning trends, novel treatments, outcomes.
2. Describe the current status of smoking-related head and neck cancer: prevalence, new risks, state of the art treatments and outcomes
3. Counsel a patient on head and neck cancer prevention and outcomes of treatment.

As a result of participation in this activity, participants should be able to:
1. Describe the presentation of chronic venous insufficiency, and identify which patients require referral to vascular surgery.
2. Distinguish chronic venous insufficiency from other causes of leg pain and leg swelling.
3. Recognize the unique pathophysiology of Post-thrombotic Syndrome.

Dr. Nicole Iovine and Dr. Philip Efrom discuss Sepsis, including medical terminology, pathophysiology, risk factors, and its critical implications within the medical field.

As a result of participation in this activity, participants should be able to: 1. Acquire proficiency in the assessment and evaluation of patients who present with symptoms suggestive of uterine myomas, recognizing the key clinical features and using appropriate diagnostic tools to confirm the diagnosis. 2. Tailor the diagnostic workup and approach for different patient populations with uterine myomas, understanding the influence of factors such as age, fertility status, and comorbidities on the clinical presentation and prognosis of the condition. 3. Adopt a patient-centered approach to managing patients with uterine myomas, considering the array of available therapeutic options, their suitability to the individual patient's needs and circumstances, and the potential complications and outcomes of each intervention.

As a result of participation in this activity, participants should be able to:
1. understand the basic concepts of MEG technology and its underlying principles, and describe the advantages of MEG compared to other neuroimaging techniques, such as functional magnetic resonance imaging (fMRI) and electroencephalography (EEG).
2. define and describe clinical and research applications of MEG in patients with neurological diseases, including epilepsy, brain tumors, Alzheimer’s disease, and Parkinson disease
3. highlight the potential future directions for MEG research and clinical applications, including its use in non-invasive brain-computer interfaces